NEW YORK, November 10, 2010 /PRNewswire/ -- Elsevier, the world's leading publisher of scientific, technical and medical information, announced today that it is partnering with the Academy of Psychosomatic Medicine (APM) to publish Psychosomatics, the official journal of the Academy of Psychosomatic Medicine. The announcement, made at the annual APM meeting in Marco Island, Florida, marks an important move by the APM and Elsevier to increase the reach of the journal, particularly to a new generation of psychiatrists, and to promote consultation-liaison psychiatry as a field of growing importance. Elsevier will begin publication of the journal as of the first issue of 2011.

Elsevier Publishing Director Josh Spieler said, This is the next step in the evolution of Psychosomatics as an international journal committed to helping its readers achieve excellence in the clinical care of patients with psychiatric and medical comorbidity. Elsevier's extensive network of global resources and publishing solutions, including Sciverse ScienceDirect, the world's premier full-text scientific database with more than 10 million peer-reviewed journal articles and book chapters and archives dating back as far as 1823, will help APM increase the reach and growth of Psychosomatics worldwide. At the same time, the new partnership adds important content to the Elsevier portfolio, enabling the publisher to continue its growth as the market leader in psychiatry journal publishing in North America and internationally.

Psychosomatics: The Journal of Consultation and Liaison Psychiatry is the official journal of the Academy of Psychosomatic Medicine. Peer-reviewed and included in leading abstracting/indexing services such as Index Medicus/MEDLINE, Psychosomatics is published six times a year and is edited by Theodore A. Stern, MD, Chief of the Psychiatric Consultation Service at Massachusetts General Hospital and Professor of Psychiatry at Harvard Medical School.

About Academy of Psychosomatic Medicine

The Academy of Psychosomatic Medicine ( represents psychiatrists dedicated to the advancement of medical science, education and health care for persons with comorbid psychiatric and general medical conditions and provides national and international leadership in the furtherance of those goals.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet ( and Cell (, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect (, SciVerse Scopus (, Reaxys (, MD Consult ( and Nursing Consult (, which enhance the productivity of science and health professionals, and the SciVal suite ( and MEDai's Pinpoint Review (, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier ( employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media Contact Christopher J. Pfister +1(215)239-3266

SOURCE: Elsevier

CONTACT: Media Contact: Christopher J. Pfister, +1(215)239-3266,